Preclinical efficacy of the combination of olaparib plus carboplatin with vandetanib in triple-negative breast cancer.
Nandini Dey
No relevant relationships to disclose
Hui Wu
No relevant relationships to disclose
Yuliang Sun
No relevant relationships to disclose
Pradip De
No relevant relationships to disclose
Brian Leyland-Jones
No relevant relationships to disclose